Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…
Severe ME/CFS patient again threatened with detention, Denmark
Psychiatrists in Denmark are still threatening to forcibly detain a severe myalgic encephalomyelitis (ME/CFS) patient in a psychiatric…